Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483938
Status:
COMPLETED
Last Update Posted:
2017-01-23
First Post:
2007-06-07
Brief Title:
The Individualized Management With Pegylated-interferon Alfa-2a Pegasys and Ribavirin Copegus Offering Viral Eradication A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C CHC Non-genotype 23 IMPROVE
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-07
First Submit QC Date:
June 7 2007
Study First Post Date:
2007-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-01-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-25
Last Update Post Date:
2017-01-23
Last Update Post Date Type:
ESTIMATED